Security key
05156V102
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH)
CUSIP: 05156V102
Q4 2017 13F Holders as of 31 Dec 2017
- Security type / class
- Equity / Common Shares, no par value
- Total 13F shares
- 23,825,802
- Total 13F value
- $107,940,708
- Share change
- +369,931
- Put/Call ratio
- 431%
- SEC-reported price per share
- $4.53
- Number of holders
- 66
- Value change
- -$515,812
- Number of buys
- 33
- Number of sells
- 28
- Shares outstanding
- 130,441,060
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2017
Institutions
66
Top holders
10
AUPH full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2018
Previous quarter: Q3 2017
Aurinia Pharmaceuticals Inc. SEC filings
Aurinia Pharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 05156V102
Recent filing periods:
Ownership snapshot
Top reported holders of AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
30 Sep 2017
13F
Lead comparable stake: 4.5%
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 4.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
4.5%
NEA Management Company, LLC
3.7%
ORBIMED ADVISORS LLC
1.4%
Polar Capital LLP
1.2%
FRANKLIN RESOURCES INC
0.96%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
4.5%
|
$36,610,000
5,838,831 shares
|
— | 30 Sep 2017 |
| NEA Management Company, LLC |
13F
Company
|
3.7%
|
$30,149,000
4,808,483 shares
|
— | 30 Sep 2017 |
| ORBIMED ADVISORS LLC |
13F
Company
|
1.4%
|
$11,270,000
1,797,400 shares
|
— | 30 Sep 2017 |
| Polar Capital LLP |
13F
Company
|
1.2%
|
$10,147,000
1,618,352 shares
|
— | 30 Sep 2017 |
| FRANKLIN RESOURCES INC |
13F
Company
|
0.96%
|
$7,838,000
1,250,000 shares
|
— | 30 Sep 2017 |
| Vivo Capital, LLC |
13F
Company
|
0.93%
|
$7,607,000
1,213,290 shares
|
— | 30 Sep 2017 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2017
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
66
Shares
23,825,802
Rows available
66
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2017 vs Q3 2017 Across Filers
Q3 2017 holders
59
Q4 2017 holders
66
Holder diff
7
| Investor | Q3 2017 Shares | Q4 2017 Shares | Share Diff | Share Chg % | Q3 2017 value | Q4 2017 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend